Dacarbazine for Injection (Hospira, Inc.)

Hazard statements (CLP)

H303, H315, H319, H335, H341, H351, H360D

Code

Statements

H303

May be harmful if swallowed

SECTION 2: Hazards identification

OSHA Classification of the substance or mixture

Signal word

Danger

Hazard statements

H303 - May be harmful if swallowed H315 - Causes skin irritation H319 - Causes serious eye irritation H341 - Suspected of causing genetic defects H351 - Suspected of causing cancer H360D - May damage the unborn child H335 - May cause respiratory irritation

Precautionary statements

EU (§28, P201 - Obtain special instructions before use 1272/2008) P202 - Do not handle until all safety precautions have been read and understood P261 - Avoid breathing dust/fume/gas/mist/vapors/spray P264 - Wash hands thoroughly after handling P271 - Use only outdoors or in a well-ventilated area P280 - Wear protective gloves/protective clothing/eye protection/face protection P308 + P313 - IF exposed or concerned: Get medical advice/attention P302 + P352 - IF ON SKIN: Wash with plenty of soap and water P332 + P313 - If skin irritation occurs: Get medical advice/attention P362 + P364 - Take off contaminated clothing and wash it before reuse P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P337 + P313 - If eye irritation persists: Get medical advice/attention P304 + P340 - IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing P312 - Call a POISON CENTER or doctor/physician if you feel unwell P301 + P312 - IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell P405 - Store locked up P501 - Dispose of contents/container in accordance with local, regional, national, and international regulations as applicable

Other hazards

An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8).

PBT Substances

& vPvB The product does not contain any substance(s) classified as PBT or vPvB. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

2.1 Classification of the substance or mixture

GHS - Classification: Regulated according to Regulation (EC) 1272/2008 and/or other applicable regulations. Acute toxicity - Oral Category 5 - (H303) Skin corrosion/irritation Category 2 - (H315) Serious eye damage/eye irritation Category 2A - (H319) Germ cell mutagenicity Category 2 - (H341) Carcinogenicity Category 2 - (H351) Reproductive toxicity Category 1B - (H360D) Specific target organ toxicity (single exposure) Category 3 - (H335) OSHA Classification Hazards not otherwise classified (HNOC) Not applicable Hazards classified under paragraph (d)(1)(ii) of 1910.1200 Not applicable